Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
September 30, 2021
2021年9月30日
Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim
獨特的五年協議將幫助總部位於費城的健康領導者整合和標準化創新的心血管護理，幫助實現四重目標
Amsterdam, the Netherlands and Philadelphia, PA – Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, andLankenau Heart Institutepart ofMain Line Health, today announced they have entered a five-year strategic partnership focused on integrated cardiovascular solutions. Working together, Philips and Main Line Health will develop an ecosystem of clinically-enabled cardiovascular solutions that will allow Main Line Health to standardize and integrate technology across its network, helping to unlock patient data for better clinical decisions, while optimizing workflows for a better patient and staff experience. In addition, the partnership aims to help Main Line Health drive predictability and consistency in costs, as well as focus on clinical and technical training.
荷蘭阿姆斯特丹和賓夕法尼亞州費城-皇家飛利浦(紐約證券交易所：PHG全球醫療技術領先企業AEX：PHIA)和美因健康旗下的蘭克瑙心臟研究所今天宣佈，雙方已達成為期五年的戰略合作伙伴關係，專注於心血管綜合解決方案。通過合作，飛利浦和主線健康公司將開發一個臨牀啟用的心血管解決方案的生態系統，使主線健康公司能夠標準化和整合其網絡中的技術，幫助解鎖患者數據以做出更好的臨牀決策，同時優化工作流程以獲得更好的患者和員工體驗。此外，這一夥伴關係旨在幫助主線健康公司提高成本的可預測性和一致性，並將重點放在臨牀和技術培訓上。
Providing care to the Philadelphia region and its western suburbs, Main Line Health is committed to delivering advanced medicine to treat and cure disease, while also playing an important role in prevention strategies and disease management. At its core are four of the region’s most respected acute care hospitals –Lankenau Medical Center,Bryn Mawr Hospital,Paoli HospitalandRiddle Hospital. Moreover, Main Line Health conducts clinical research in the latest health care innovations and trains physicians and other health care providers to ensure its staff can provide the best, most advanced care to the communities they serve.
主線健康公司為費城地區及其西郊提供護理，致力於提供先進的治療和治療疾病的藥物，同時在預防戰略和疾病管理方面發揮重要作用。它的核心是該地區四家最受尊敬的急性護理醫院-蘭克瑙醫療中心、布林·毛爾醫院、保羅醫院和裏德爾醫院。此外，Main Line Health在最新的醫療創新方面進行臨牀研究，並培訓醫生和其他醫療保健提供者，以確保其員工能夠為他們所服務的社區提供最好、最先進的醫療服務。
“Through this innovative business model, we will have a technology partner who can help us adopt the solutions that will not only help us drive operational efficiency, they will allow us to expand the type of quality care our patients have come to expect,” said Trudy Mazzone, MS, BSRT, (R), System Director, Main Line Health Cardiovascular Services and Co-director, Lankenau Heart Institute.
主線健康心血管服務部系統主任、蘭克瑙心臟研究所聯席主任特魯迪·馬茲宗(註冊商標)説：“通過這種創新的商業模式，我們將擁有一個技術合作夥伴，他可以幫助我們採用解決方案，這些解決方案不僅有助於我們提高運營效率，還將使我們能夠擴大我們的患者所期望的高質量護理類型。”(註冊商標)主線健康心血管服務系統主任兼蘭克瑙心臟研究所聯席主任特魯迪·馬茲宗(Trudy Mazzone，MS，BSRT，(R))説。
“By partnering with Philips, we will be able to continue our world-class cardiovascular care system-wide, including fully renovating and installing state-of-the-art Philips equipment to provide advanced cardiovascular and neuro care at Bryn Mawr Hospital and Paoli Hospital,” said William Gray, MD, System Chief, Cardiovascular Diseases, Main Line Health and Co-director, Lankenau Heart Institute. “This will allow us to define a strategy for the future, adopting novel technology as it evolves.”
“通過與飛利浦公司合作，我們將能夠在整個系統內繼續我們世界級的心血管護理，包括全面翻新和安裝飛利浦最先進的設備，在布林莫爾醫院和保利醫院提供先進的心血管和神經護理。”蘭克瑙心臟研究所心血管疾病、主線健康和聯席主任、醫學博士威廉·格雷(William Gray)説：“通過與飛利浦合作，我們將能夠在整個系統內繼續我們世界級的心血管護理，包括全面翻新和安裝飛利浦最先進的設備，在布林莫爾醫院和保利醫院提供先進的心血管和神經護理。這將使我們能夠確定未來的戰略，在新技術發展的過程中採用它。“
This long-term strategic partnership will uniquely focus on integrated cardiovascular solutions. As part of the partnership, a dedicated team of Philips solutions architects will work collaboratively with Main Line Health to understand their challenges and develop technology plans around the cardiovascular service line. These technology plans are tailored to their needs with three objectives in mind: clinical, operational and business model innovation.
這一長期戰略伙伴關係將獨特地專注於綜合心血管解決方案。作為合作關係的一部分，一個由飛利浦解決方案架構師組成的專門團隊將與主線健康公司合作，瞭解他們面臨的挑戰，並圍繞心血管服務線制定技術計劃。這些技術計劃是根據他們的需求量身定做的，有三個目標：臨牀、運營和商業模式創新。
Philips brings over a century of experience in healthcare, providing best practices in world class facility planning and design, intelligent technology implementation, data analytics and IT integration, and education management, as well as workflow and performance optimization.
飛利浦在醫療保健領域擁有超過一個世紀的經驗，在世界級設施規劃和設計、智能技術實施、數據分析和IT集成、教育管理以及工作流程和性能優化方面提供最佳實踐。
“Healthcare technology is evolving at a rapid rate and partnering with Main Line Health will allow us to understand patient needs and workflows, map them to the right solutions and help them to deliver on the quadruple aim,” said Vitor Rocha, Market Leader for Philips North America. “Together we can help them keep pace with technology, allowing them to focus on what is most important: providing high quality care, positive patient outcomes and a superior patient experience for their community.”
飛利浦北美市場主管維託·羅查(Vitor Rocha)表示：“醫療保健技術正在快速發展，與Main Line Health的合作將使我們能夠了解患者的需求和工作流程，將它們映射到正確的解決方案，並幫助他們實現四重目標，”飛利浦北美市場主管維託·羅查(Vitor Rocha)説。我們可以共同幫助他們跟上技術的步伐，使他們能夠專注於最重要的事情：為他們的社區提供高質量的護理、積極的患者結果和卓越的患者體驗。“
William Gray has a consulting relationship with Philips.
威廉·格雷與飛利浦有諮詢關係。
For further information, please contact:
如需更多信息，請聯繫：
Philips Silvie CasanovaPhilips North AmericaTel: +1 781 879 0692silvie.casanova@philips.com
飛利浦電話：+1 781 879 0692silvie.casanova@Philips.com
Joost MalthaPhilips Global Press OfficeTel: +31 610 558 116Email:joost.maltha@philips.com
Joost MalthaPhilips全球新聞辦公室電話：+31 610 558 116電子郵件：Joost.Maltha@Philips.com
Main Line Health Samantha KrouseManager, CommunicationsTel: +1 484 580 1059Krouses@mlhs.org
主線運行狀況通訊部經理Samantha KrouseManager電話：+1 484 580 1059Krouse@mlhs.org
About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found atwww.philips.com/newscenter.
關於皇家飛利浦公司皇家飛利浦(紐約證券交易所股票代碼：PHG，AEX：PHIA)是一家領先的健康技術公司，專注於改善人們的健康和福祉，並在整個健康體系中實現更好的結果-從健康生活和預防，到診斷、治療和家庭護理。飛利浦利用先進的技術和深入的臨牀和消費者洞察力提供集成的解決方案。該公司總部設在荷蘭，是診斷成像、圖像引導治療、患者監測和健康信息學以及消費者健康和家庭護理領域的領先者。飛利浦2020年的銷售額為173億歐元，擁有約77,000名員工，銷售和服務遍及100多個國家。有關飛利浦的新聞可以在www.Philips.com/newscenter上找到。
About Lankenau Heart Institute TheLankenau Heart Instituteis Main Line Health’s premier, comprehensive cardiovascular medicine and surgery program. The Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, the Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
關於蘭克瑙心臟研究所蘭克瑙心臟學院是主線健康中心首屈一指的綜合性心血管內科和外科項目。蘭克瑙心臟研究所彙集了所有四家主線健康急性護理醫院的臨牀專業知識和社區心臟病學實踐，以確保患者獲得該地區前所未有的質量、服務和體驗。通過全系統的服務協調，蘭克瑙心臟研究所在蘭克瑙醫療中心、Bryn Mawr醫院、Paoli醫院和裏德爾醫院等每個地點提供預防、診斷、治療和康復心血管服務。
Lankenau Heart Institute continues to be a pioneer in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, and complex aortic surgeries. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate minimally invasive procedures/approaches.
蘭克瑙心臟研究所繼續是使用心臟跳動技術和機器人輔助的冠狀動脈血運重建、瓣膜修復和置換的微創和經導管方法以及複雜的主動脈手術的先驅。隨着我們不斷積累的經驗和對微創技術的關注，蘭克瑙心臟研究所每年都在擴大對臨牀試驗的參與。我們的醫生經常被邀請參加臨牀/醫療器械試驗，其中許多試驗旨在促進微創程序/方法。
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained nurses and technologists, the Lankenau Heart Institute is dedicated to managing and treating patients with heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.
蘭克瑙心臟研究所擁有一支由專家諮詢心臟病學家、介入心臟病學家、電生理學家、心血管外科醫生以及受過專門培訓的護士和技術員組成的協作團隊，致力於管理和治療心力衰竭、主動脈疾病、冠狀動脈和外周血管疾病、心律紊亂和瓣膜疾病患者。我們的心臟病專家和心臟病專家團隊為患者及其家人提供離家很近的專業心臟護理。
About Main Line Health Founded in 1985, Main Line Health is a not-for-profit health system serving portions of Philadelphia and its western suburbs. Main Line Health’s commitment—to deliver advanced medicine to treat and cure disease while also playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to keep our community and ourselves well ahead. A team of more than 10,000 employees and 2,000 physicians care for patients throughout the Main Line Health system.
關於主線健康Main Line Health成立於1985年，是一個非營利性的醫療系統，服務於費城及其西郊的部分地區。主線健康的承諾-提供先進的治療和治療疾病的藥物，同時在預防和疾病管理以及培訓醫生和其他醫療保健提供者方面發揮重要作用-反映了我們讓我們的社區和我們自己保持領先的意圖。一支由10,000多名員工和2,000多名醫生組成的團隊在整個主線醫療系統中為患者提供護理。
At Main Line Health’s core are four of the region’s most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation’s recognized facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
主線健康的核心是該地區四家最受尊敬的急性護理醫院-蘭克瑙醫療中心、布林·毛爾醫院、保羅醫院和裏德爾醫院-以及一布萊恩·莫爾康復醫院是全國公認的康復醫療機構之一。
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region’s largest multispecialty physician networks.
主線健康中心還包括：米爾蒙治療中心，用於藥物和酒精恢復；主線健康家庭護理和臨終關懷，包括熟練的家庭保健、臨終關懷和家庭輸液服務；主線健康中心，初級和專科護理，實驗室和放射科，以及位於布魯馬爾、科勒維爾、康科德維爾、埃克斯頓、普魯士國王和紐敦廣場的其他門診服務；蘭克瑙醫學研究所，一個生物醫學研究機構；以及主線醫療，該地區最大的多科醫生之一。
Main Line Health is the recipient of numerous awards for quality care and service, including System Magnet® designation, the nation’s highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect and inclusion and has proudly embraced the American Hospital Association’s #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education and research to help our community stay healthy.
Main Line Health是眾多優質護理和服務獎項的獲得者，其中包括System Magnet®認證、美國卓越護理的最高榮譽以及大西洋中部卓越績效聯盟(MAAPE)卓越獎(Mid-Atlantic Alliance for Performance Performance，MAAPE)卓越獎。主線健康致力於創造一個多元化、尊重和包容的環境，並自豪地接受了美國醫院協會(American Hospital Association)的#123公平承諾法案(#123 for Equity Pledge to Act)，以消除醫療保健方面的差異。我們致力於推進以病人為中心的護理、教育和研究，以幫助我們的社區保持健康。
Attachments
附着物
Lankenau Heart Institute, part of Main Line Health
蘭克瑙心臟研究所，主線健康的一部分
Case review at Lankenau Heart Institute
蘭克瑙心臟研究所的病例回顧
譯文內容由第三人軟體翻譯。